What to know about antibody sequence analysis software
Antibody sequence analysis software, such as the Dotmatics platform powered by Geneious, facilitates the validation, characterization, selection, visualization, and export of antibody sequences—enabling scientists to efficiently analyze data from sources like Next-Generation Sequencing to support rational design and development of therapeutic antibodies.
Antibody sequences are important for engineering antibodies and characterizing proteins.
Knowing antibody sequences allows for rational experimental design for the development of potentially lifesaving therapeutics. Successful and efficient antibody sequencing requires the assistance of digital tools, and these tools are referred to as antibody sequence analysis software.
Antibody sequence analysis software is designed to help identify and characterize antibody sequences, allowing scientists to gain valuable insight into antibody sequences, and easily share and visualize results.
Antibody sequence analysis tool functionalities
Antibody sequence analysis tools enable scientists to:
- Validate antibody sequences: Automatically apply annotations, validate different types of antibody sequences, and view closest germline gene matches.
- Select optimal candidates: Discover liabilities and other sequence features, pinpoint variants of mutations, and filter data to choose representative sequences.
- Visualize and export results: Analysis results can be explored using interactive sequence viewers, grouping sequences by genes or regions, and exporting tables and images for reporting.
How to use antibody sequence analysis software
Antibody sequence analysis software is easy to use and built tailored for your needs. This is especially true for Dotmatics platform, which offers tools for easy and accurate antibody sequencing.
Dotmatics supports lab insights by offering a dynamic workflow that groups key capabilities into packages. Dotmatics also provides advanced analytics and easy-to-understand visualizations for many different antibody-like molecules.
This package, powered by Geneious, provides analytics and visualizations for a range of antibody-like molecules. It also helps to extract the maximum information from many different data sets, including:
- Next-Generation Sequencing (NGS): A robust technology used to determine the sequence of DNA or RNA for studying genetic variations associated with diseases.
- Single Cell Sequencing: Sequencing of individual cells with optimized sequencing technologies.
- Sanger Sequencing: Sequencing method for determining the nucleotide sequence of DNA based on using electrophoresis.
Dotmatics software, supported by Geneious, uses innovative algorithms to achieve unprecedented accuracy, accelerated candidate selection, and superior visualizations. You can easily annotate, validate, and characterize IgG-like antibody sequences and improve your productivity and performance in the lab using this powerful tool.
Related
Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics has launched the Luma Antibody & Protein Engineering Solution, the first in its Luma Multimodal R&D Solutions series, which integrates the Dotmatics Luma Scientific Intelligence Platform with key tools like Geneious, GraphPad Prism, and others to streamline and unify antibody discovery and development—particularly for monoclonal and multispecific antibodies—while supporting a broad range of therapeutic modalities including CAR-T, siRNA, ADCs, CRISPR, and vaccines within a collaborative, multimodal research environment.
Stop Compromising on Speed or Accuracy in Antibody Discovery
The article outlines how antibody discovery teams can simultaneously improve speed and accuracy by adopting a collaborative workflow involving three key steps—target identification using a query tool for antibody searches, target screening with customizable parameters and integrated data management, and candidate selection through bioassay data association and sequence alignment—highlighting Dotmatics Biology Solution for Antibody Discovery as a tool to streamline these processes.
New Dotmatics solution to streamline your antibody discovery process
Dotmatics' new Luma Antibody & Protein Engineering solution, built on the AI-native Geneious Luma platform and integrated with tools like GraphPad Prism, streamlines the complex antibody discovery and development process by unifying data, teams, and experimental phases within a single, collaborative environment to enhance biologics R&D productivity and overcome challenges of siloed data and rigid workflows.
SoftGenetics Joins Dotmatics, Expanding the Platform into Clinical and Forensic Genetics
Dotmatics has acquired SoftGenetics, a bioinformatics software company with over 22 years of expertise in advanced genetic analysis tools used in research, clinical, and forensic applications, thereby expanding Dotmatics' platform to enhance scientific discovery and improve clinical outcomes while maintaining SoftGenetics as a standalone business.
Joining Forces with Insightful Science
Dotmatics and Insightful Science have merged to form the world’s largest cloud-based scientific research R&D platform, combining their software solutions to accelerate innovation, enhance data-driven research workflows, and drive the digital transformation of scientific labs into the Lab of the Future.
Webinar: Identification, Screening, and Selection of Antibodies of Interest
The webinar, presented by Kelly Harrington, Jessica Biagi, and Monica Watson, demonstrates how the Dotmatics platform streamlines and accelerates the antibody selection process through easy target searching, automated assay analysis, and integration with Geneious software to create a collaborative and efficient workflow.